Germ cell fate decisions are poorly understood, despite their central role in reproduction. One fundamental question has been whether germ cells are regulated to enter the meiotic cell cycle (i.e., mitosismeiosis decision) and to be sperm or oocyte (i.e., sperm-oocyte decision) through one or two cell fate choices. If a single decision is used, a male-specific or female-specific meiotic entry would lead necessarily toward spermatogenesis or oogenesis, respectively. If two distinct decisions are used, meiotic entry should be separable from specification as sperm or oocyte. Here, we investigate the relationship of these two decisions with tools uniquely available in the nematode Caenorhabditis elegans. Specifically, we used a temperature-sensitive Notch allele to drive germ-line stem cells into the meiotic cell cycle, followed by chemical inhibition of the Ras/ERK pathway to reprogram the sperm-oocyte decision. We found that germ cells already in meiotic prophase can nonetheless be sexually transformed from a spermatogenic to an oogenic fate. This finding cleanly uncouples the mitosis-meiosis decision from the sperm-oocyte decision. In addition, we show that chemical reprogramming occurs in a germ-line region where germ cells normally transition from the mitotic to the meiotic cell cycle and that it dramatically changes the abundance of key sperm-oocyte fate regulators in meiotic germ cells. We conclude that the C. elegans mitosis-meiosis and sperm-oocyte decisions are separable regulatory events and suggest that this fundamental conclusion will hold true for germ cells throughout the animal kingdom. G erm cells make two major cell fate choices. One is a cell cycle decision and one is a sexual fate decision. During the course of their development, germ cells are regulated to transition from the mitotic to the meiotic cell cycle, and they are regulated to produce sperm in males or oocytes in females. A fundamental question in the germ cell field has been whether the mitosis-meiosis and sperm-oocyte decisions represent one or two regulatory events (1) . If a single decision, germ cells might decide between male-specific meiotic entry leading to spermatogenesis or female-specific meiotic entry leading to oogenesis. If two distinct decisions, germ cells would be regulated to enter the meiotic cell cycle in a way that is separable from their sexual fate decision. Major progress has been made in understanding regulation of the mitosis-meiosis decision (2) , but the sperm-oocyte decision has been less tractable in most organisms. Here we investigate the relationship between the mitosis-meiosis and sperm-oocyte decisions in the nematode Caenorhabditis elegans, in which molecular regulators of the two decisions can be manipulated independently.
C. elegans adults exist as XO males or self-fertile XX hermaphrodites. Males produce sperm continuously; hermaphrodites make oocytes continuously in adults, after generating a limited number of sperm as larvae. In both sexes, the adult germ-line tissue is organized linearly along its distal to proximal axis: at the distal end, germ cells in the mitotic cell cycle occupy the "mitotic zone" (MZ); more proximally, germ cells enter the meiotic cell cycle and progress through meiotic prophase; germ cells terminally differentiate as sperm or oocytes at the proximal end (Fig. 1A) . Germ cells move from distal to proximal as they progressively mature.
Regulators of the mitosis-meiosis decision have been identified and can be manipulated in C. elegans (3). The stem cell niche at the distal end (Fig. 1A, red) employs Notch signaling to maintain germ cells in the mitotic cell cycle and prevent meiotic entry. Without the C. elegans Notch receptor GLP-1 (Germ Line Proliferation-1), all mitotic germ cells enter the meiotic cell cycle and differentiate. A glp-1 ts (temperature-sensitive) mutant maintains the MZ at permissive temperature (15°C), but, at the restrictive temperature (25°C), all germ cells (including germ-line stem cells) enter the meiotic cell cycle (Fig. 1B) . Therefore, glp-1(ts) mutants provide a powerful tool for manipulating the mitosis-meiosis decision in adults.
Regulators of the sperm-oocyte decision have also been identified and can be manipulated in C. elegans (3, 4) . C. elegans germ cell sex relies on somatic signaling plus germ cell-specific spermoocyte fate regulators that respond to the somatic signals (3, 5) . By manipulating sperm-oocyte fate regulators with temperaturesensitive mutants, RNA-mediated interference, or small molecule intervention, adults making sperm can be transformed to make oocytes without affecting somatic sex (e.g., refs. 4, 6, 7) . Such a transformation from sperm to oocyte production can be induced in WT XO adult males or in XX adult hermaphrodites with an aberrantly masculinized germ line. Adults making oocytes can also be transformed to make sperm, again without affecting somatic sex (8) . Germ-line sexual transformation does not appear to convert mature sperm into oocytes or vice versa, but instead switches the adult tissue from production of a gamete of one sex (e.g., sperm) into production of the other (e.g., oocyte).
One sperm-oocyte fate regulator is the C. elegans homologue of ERK/MAPK, called MPK-1 (9) . We previously found that chemical inhibitors of Ras/ERK signaling can reprogram adults from sperm to oocyte production when applied in a puf-8;lip-1 sensitized mutant background (4) (Fig. 1C) . XX puf-8;lip-1 adult germ lines make sperm instead of oocytes, likely because of the dual loss of the puf-8 oocyte fate regulator (10) and the lip-1 dual specificity phosphatase, which leads to hyperactivation of the MPK-1/ERK sperm fate regulator (9, 11) . Importantly, this chemically induced oogenesis generates functional oocytes that support embryogenesis (4). Treatment with Ras/ERK inhibitors therefore provides a method to manipulate the sperm-oocyte decision quickly (mature oocytes are seen 24 h after treatment) and independently of a temperature shift.
In this study, we manipulate the mitosis-meiosis and spermoocyte decisions independently and find that they can be uncoupled: germ cells in meiotic prophase can be sexually transformed from a spermatogenic to an oogenic cell fate. We also find that the sperm-to-oocyte fate chemical reprogramming occurs in a region in the distal germ line where cells transition from the mitotic to the meiotic cell cycle, and that it is accompanied by dramatic changes in key sperm-oocyte fate regulators. Together these results provide compelling evidence that the mitosis-meiosis and sperm-oocyte decisions are separable regulatory events.
Results and Discussion
Mitosis-Meiosis and Sperm-Oocyte Decisions Are Separable. We used a simple experimental design to ask if the mitosis-meiosis and sperm-oocyte decisions are separable regulatory events (Fig.   1D ). We first generated glp-1(ts);puf-8;lip-1 triple mutants, a strain in which glp-1(ts) permitted temperature manipulation of the mitosis-meiosis decision and puf-8;lip-1 permitted chemical manipulation of the sperm-oocyte decision. We then asked how long after being shifted to restrictive temperature (25°C) germ cells entered the meiotic cell cycle. Specifically, we assayed S-phase with incorporation of the thymidine analogue 5-ethynyl- 2′-deoxyuridine (EdU) (12) and meiotic entry with staining of chromosomal HIM-3, a synaptonemal complex protein and established marker of cells in the meiotic cell cycle (13) . In both assays, DAPI staining was also used to monitor nuclear morphology diagnostic of various stages of meiotic prophase. We found that EdU incorporation ceased within 8 h after the shift to 25°C ( Fig. 1 E and F), suggesting that mitotic and meiotic S-phase were complete by that time. We also found that chromosomal HIM-3 was present in all germ cells within 6 h after the shift ( Fig.  1 G-I), suggesting that meiotic entry was complete. By nuclear morphology, most germ cells had entered early meiotic prophase 6 h after the shift, and all had done so 8 h after the shift (Fig. S1 ). Therefore, a shift of glp-1(ts);puf-8;lip-1 triple mutants to 25°C drives most germ cells into meiotic prophase by 6 h, and all germ cells are in meiotic prophase by 8 h.
To ask if we could reprogram meiotic prophase germ cells from sperm to oocyte production, we shifted the glp-1(ts);puf-8;lip-1 triple mutants to restrictive temperature for 6, 8, or 10 h and then applied the MEK kinase inhibitor U0126 and scored gametes after 24 h (Fig. 1D) . Production of mature sperm or oocytes was scored by using gamete-specific molecular markers (sperm, SP56; oocyte, OMA-2), cellular morphology (3), and embryo generation. None of the DMSO solvent-treated control germ lines made oocytes ( Fig. 1 J-L, Upper), but U0126-treated germ lines were reprogrammed from sperm to oocyte production ( Fig. 1 J-L, Lower). Moreover, the reprogrammed germ lines made functional oocytes, as assayed by embryo production. One might like to ask if meiotic germ cells could similarly be forced from oocyte to sperm generation, but this opposite transformation cannot yet be exerted chemically. We conclude that the sperm-oocyte fate decision can be reprogrammed after entry into meiotic prophase, a result that unambiguously shows that the mitosis-meiosis and sperm-oocyte decisions are separable regulatory events. A corollary to this conclusion is that other sex-specific features of germ cells (e.g., mitotic cell cycle lengths, meiotic progression rates) may also be separable from the sperm-oocyte fate decision.
Sperm-Oocyte Fate Reprogramming Maps to Transition from Mitotic
to Meiotic Cell Cycle. By using the puf-8;lip-1 double mutant on its own [without the glp-1(ts) mutation], we generated a map of the anatomical region where germ cells undergo the process of sperm-oocyte fate reprogramming. We subsequently mapped the site of meiotic entry in this same mutant for comparison. By convention, germ cell position is measured along the gonadal distal to proximal axis in number of germ cell diameters (gcds) from the distal end; because several germ cells reside at each position, each position is called a row for brevity (see Fig. 3A ). To deduce the site of reprogramming, we measured several values, all in U0126-treated puf-8;lip-1 adult germ lines. The rate of germ cell movement, μ, was 1.4 gcds/h (Fig. 2B and Fig. S2) ; the position at which the first grossly differentiated oocyte appeared, X ω , was 34.4 gcds ± 1.8 (n = 29); and the time elapsed from U0126 addition to appearance of the first induced oocyte, t, spanned 16 to 22 h (Fig. 2 C and D) . Because t was not a single value, we interpolated values across the t-value range to generate t i (Dataset S1). We also assayed how fast ERK activity was lowered in response to U0126 addition and how fast it recovered after removal ( Fig. S3 A and B) . Because ERK inhibition occurred so rapidly after U0126 addition (15 min), t i values were not corrected for time required for drug response. We deduced the position at which reprogramming begins, X oi , by using the equation X oi = X ω − μt i (Fig. 2E, blue bars; and Fig. S4 ). The X oi values spanned germ cell rows 3 through 11 (Fig. 2E , blue bars; Dataset S1), with most mapping to rows 4 to 10 (Fig. 2E, blue  bars) . Therefore, germ-line sex reprogramming does not occur in the distal-most germ cells in the stem cell niche, but instead it begins after the germ cells have begun to move proximally to leave the niche.
In addition to mapping where chemical reprogramming begins within the germ line, we also mapped where reprogramming finishes. To this end, we first determined Δ, the length of time ERK must be inhibited to accomplish reprogramming. Specifically, we measured the length of a U0126 pulse necessary for reprogramming and corrected that pulse length for the time required to recover ERK activity after drug removal (Fig. S5 A and  B) . Animals were treated with increasingly long U0126 pulses and then scored for sperm-oocyte fate reprogramming after 24 h from initial drug exposure to permit the generation of mature oocytes. An 8-h U0126 pulse reprogrammed all animals, whereas pulses as short as 2 h also worked, but in fewer animals (Fig. S5A) . When corrected for the 1-h time of ERK recovery, we estimated that a Δ of 3 to 9 h ERK inhibition was required for reprogramming (Fig. S5B) . Because Δ was not a single value, we interpolated values across the Δ-value range, or Δ i (Dataset S2), and applied equation X αi = X ω − μ(t i − Δ i ) to estimate X αi , the position at which germ cells had completed reprogramming (Fig. 2E , red bars; and Fig. S5C ). The X αi values spanned rows 11 through 15, with most X αi falling into rows 11 to 13 (Fig. 2E, red bars; and Dataset S2). A conservative estimate, gleaned from the extents of X oi and X αi , indicates that reprogramming of gamete sex is likely initiated between cell rows 3 and 11 and completed between rows 11 and 15 in the distal germ line (Fig. 2E) . It is important to note that these values are rough estimates, as they cover reprogramming in all germ cells, not a single germ cell, and use variables (e.g., X ω , μ, t i , and Δ) from multiple experiments.
To relate the region of germ-line sex reprogramming to the site of meiotic entry, we next mapped where germ cells transition from the mitotic to the meiotic cell cycle in puf-8;lip-1 mutants. That transition is best gleaned by using the combined results of a series of markers. Staining with the antibody to phosphohistone H3, a marker of mitotic M-phase, was restricted to rows 1 to 12, with the vast majority in rows 1 to 10 ( Fig. 2F and Fig. S6 A and B) . Labeling with a 30-min pulse of thymidine analogue EdU, a marker incorporated into DNA during mitotic and meiotic S-phase, was limited to rows 1 to 14 ( Fig. 2F and Fig. S6C ). Chromosomal HIM-3 staining (HIM-3 is a marker of meiotic entry) extended proximally from row 11 ( Fig. 2F and Fig. S6D ). Cells in early meiotic prophase, detected as crescent-shaped nuclei after DAPI staining, spanned rows 13 to 20 ( Fig. 2F and Fig.  S6A ). These findings together indicate that most puf-8;lip-1 germ cells are maintained in the mitotic cell cycle until row ∼10, that most enter meiotic S-phase at row ∼11, and that most enter meiotic prophase at row ∼13. By comparison, our estimate of the sperm-oocyte reprogramming region spanned rows 3 to 15. Therefore, gamete sex reprogramming appears to begin in mitotically dividing germ cells and to be completed in early meiotic prophase germ cells. The coincidence of meiotic entry with the sperm-oocyte fate decision was inferred previously (6), as was the distal germ line as the site of the sperm-oocyte decision (10, 14, 15) . Our results are consistent with those inferences and support the notion that chemical reprogramming of the sperm-oocyte fate decision is likely to reflect the normal sperm-oocyte fate decision.
We conclude that chemical reprogramming of the sperm-oocyte decision occurs in a region spanning the proximal MZ and distal transition zone (TZ), and suggest that commitment to sperm or oocyte development normally occurs in the same region. Consistent with this physical mapping, previous studies found that germ cells in the proximal MZ are actively transitioning from a stem cell-like state to a differentiated state (16) . Intriguingly, germ cells in the MZ are also uniquely susceptible to reprogramming into neurons after removal of just one chromatin factor (17) . Perhaps germ cells in the proximal MZ have acquired a "transient regulatory state" (18) , which is particularly vulnerable to reprogramming.
Key Sperm-Oocyte Fate Regulators Change Abundance upon Chemical
Reprogramming. The sperm-to-oocyte fate reprogramming of puf-8;lip-1 mutants relies on established germ-line sex regulators, including ERK/MPK-1 and FOG-1 (4, 6, 9). To investigate the effect of reprogramming on the sex-specific expression of these and other germ-line sex regulators, we assayed their transcript and protein abundance, focusing on regulators at the end of the germ-line sex determination pathway (Fig. 3A) . By quantitative PCR, the mRNA abundance of all eight regulators assayed (mpk-1, fog-1, gld-1, fog-3, tra-1, fem-3, gld-2, and rnp-8) was essentially unchanged at 2 and 8 h after U0126 addition compared with control ( Fig. 3 B and C and Fig. S7 B and C) . Therefore, reprogramming occurs without a significant change in abundance of transcripts encoding these key terminal sperm-oocyte fate regulators. We did, however, find abundance changes in three spermoocyte fate regulatory proteins: the sperm-promoting form of MPK-1/ERK [diphosphorylated MPK-1 (dpMPK-1)] (19), spermpromoting FOG-1 (6), and oocyte-promoting GLD-1 (20) . Activated dpMPK-1 was easily detectable in the TZ of spermatogenic DMSO-treated control germ lines (Fig. 3D, Upper) , a pattern typical of spermatogenic germ lines (19) , but was barely detectable in U0126-treated germ lines 30 min after drug treatment (Fig. 3D,  Lower) , a pattern typical of oogenic germ lines (19) . This U0126 effect on dpMPK-1 was predicted: U0126 inhibits MEK (21) and activates MPK-1 to its diphosphorylated form. The decrease in dpMPK-1 upon drug addition is consistent with our previous finding that U0126 induces chemical reprogramming specifically through inhibition of Ras-ERK signaling in puf-8;lip-1 mutants (4).
In addition, FOG-1 protein decreased sharply in the TZ within 2 h of U0126 addition (Fig. 3E) , changing from a typical spermatogenic pattern to a typical oogenic pattern of FOG-1 expression (22) . Finally, the oocyte-promoting GLD-1 protein expanded dramatically within 8 h of treatment from a small patch at the MZ/TZ border in DMSO-treated germ lines to a large area extending into the pachytene zone of U0126-treated germ lines (Fig. 3 F and G) . This change again shifts from a spermatogenic to an oogenic pattern of GLD-1 expression (23) . The U0126-induced changes in FOG-1 and GLD-1 likely reflect the downstream readout of sperm-to-oocyte reprogramming. We conclude that chemical reprogramming induces dramatic changes in three major regulators of germ-line sex determination.
The striking changes in sperm-oocyte fate regulators observed upon chemical reprogramming strongly support the idea that reprogramming operates through the normal sperm-oocyte cell fate machinery, as previously suggested (4) . The mechanism inducing these changes is likely exerted at a posttranscriptional or posttranslational level, because corresponding mRNAs did not change in abundance. We speculate that MPK-1/ERK activity may exert its effect on the sperm-oocyte decision by controlling terminal germ-line sex regulators. We also note that reprogramming-induced changes of germ-line sex regulators were most impressive in germ cells that had entered early meiotic prophase, consistent with our findings that the sperm-oocyte decision can be reprogrammed after entry into the meiotic cell cycle and that the physical map of reprogramming extends into the meiotic zone.
Conclusion
A longstanding question in metazoan germ cell biology has been whether the mitosis-meiosis and sperm-oocyte cell fate choices are one or two regulatory events (see the Introduction). We have found that the mitosis-meiosis and sperm-oocyte decisions are separable and therefore cannot be a single event. This conclusion seems intuitive for organisms whose regulators of meiotic entry act in both males and females (24) (25) (26) . However, this conclusion has been difficult to confirm experimentally because the regulatory pathways underlying the two decisions are intimately coupled, with meiotic entry regulators affecting the sperm-oocyte decision and vice versa. For example, FOG-1 and FOG-3 are not only major regulators of sperm fate specification, but they also have a role in the mitosis-meiosis decision (6, 15, 27, 28) . Similarly, GLD-1 and GLD-2 are not only major regulators of meiotic entry, but they also promote the oocyte fate (24, 29) . A closely linked relationship also holds true for mitosis-meiosis and mating type regulation in the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe (e.g., refs. [30] [31] [32] [33] [34] . Given the theme of coupled but separate regulation in C. elegans and the yeasts, we propose that the mitosis-meiosis and sperm-oocyte cell fate choices are likely to be two regulatory events in all germ cells.
Materials and Methods
Strains. Nematodes were maintained as described previously (35) . puf-8 (q725);lip-1(zh15) homozygotes were picked from a strain containing balancer mIn1[mIs14 dpy-10(e128)]. glp-1(q224 ts);puf-8(q725);lip-1(zh15) animals were obtained similarly.
Chemical Reprogramming. Chemical treatments were performed as described previously (4) . Briefly, nematodes were treated in liquid culture, including S-Media and OP50 Escherichia coli, as indicated. Differential interference contrast microscopy was used to monitor the percentage of germ lines with oocytes after treatments.
Germ Cell Position and Germ-Line Regions. Position within the germ line was measured in gcds from the distal end as described previously (36) .
Temperature Shifts. glp-1(q224ts);puf-8(q725);lip-1(zh15) animals were collected at L1 arrest and grown to the mid-L4 larval stage at 15°C. To initiate the temperature shift, animals were picked into 25°C M9 buffer for ∼5 min, and transferred to 25°C nematode growth media plates for the indicated times. Chemical reprogramming of glp-1(q224ts);puf-8(q725);lip-1(zh15) animals was conducted as described earlier, except animals were maintained at 25°C. Western Blot Analysis. Semiquantitative Western blotting was performed as described previously (4) . Briefly, active diphosphorylated MPK-1/ERK was detected with 1:5,000 mouse monoclonal anti-pTEpY ERK-1 (Sigma-Aldrich) and 1:10,000 HRP-conjugated anti-mouse (Jackson ImmunoResearch). After stripping with Restore Plus Western Blot Stripping buffer (Pierce), blots were reblocked and total MPK-1/ERK was detected with 1:20,000 rabbit anti-ERK-1/2 (Sc94; Santa Cruz Biotechnology) and 1:10,000 HRP-conjugated antirabbit (Jackson ImmunoResearch). Blots were restripped and reblocked, and ∝-tubulin was detected with 1:10,000 mouse monoclonal anti-∝-tubulin (Sigma-Aldrich) and 1:10,000 HRP-conjugated anti-mouse. The relative activity of MPK-1/ERK was determined by normalizing active MPK-1/ERK signal and total MPK-1/ERK signal to ∝-tubulin with the program ImageJ (40).
EdU Labeling. The Click-iT EdU Imaging Kit (Invitrogen) was used to label DNA via incorporation of a "clickable" thymidine analogue, EdU (12) . For germ cell rate of movement experiments, labeling was performed by feeding animals EdU-labeled E. coli for 30 min, followed by growth in liquid culture containing 50 μM U0126 in DMSO (or DMSO alone), S-media, and OP50 E. coli. For glp-1 (q224 ts);puf-8(q725);lip-1(zh15) experiments, animals were labeled by incubation for 30 min in M9 buffer containing 100 μM EdU. Germ lines were then extruded and fixed, and the incorporated EdU was visualized after conjugation to Alexa Fluor 488 azide. Total DNA was visualized by DAPI staining.
Quantitative PCR. Total RNA was isolated from worm extract using TRIzol (Invitrogen) and the RNeasy Micro Kit (Qiagen) following the manufacturer's protocols. Oligo-dT-primed cDNA was prepared from total RNA samples by using a SuperScript First-Strand Synthesis System for RT-PCR (Invitrogen) following manufacturer's protocols. To quantify specific transcript levels, quantitative PCR was performed by using TaqMan Gene Expression Master Mix (Applied Biosystems) and TaqMan Gene Expression Assays (Applied 
